In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 4, 2009, Pages 447-449

  Song, Wonkeun ^a   Suh, Borum ^b   Choi, Jun Yong ^b   Jeong, Seok Hoon ^b   Jeon, Eun Hee ^b   Lee, Young Ki ^a   Hong, Seong Geun ^c   Lee, Kyungwon ^b  

^a Hallym University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c CHA University   (South Korea)

Author keywords

Carbapenems; DHA 1; IS5; OmpK35; OmpK36

Indexed keywords

AMIDE; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; IMIPENEM; MEROPENEM; PORIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; DRUG SUBSTITUTION; FEMALE; GENE INACTIVATION; GENE INSERTION; GENE LOSS; HUMAN; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEPSIS; URINARY TRACT INFECTION;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; DNA, BACTERIAL; FEMALE; GENE DELETION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS; PORINS; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; THIENAMYCINS;

EID: 71549148077     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.08.010     Document Type: Article

References (11)

1. Doumith M., Ellington M.J., Livermore D.M., and Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63 (2009) 659-667
2. Elliott E., Brink A.J., van Greune J., Els Z., Woodford N., Turton J., Warner M., and Livermore D.M. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis 42 (2006) e95-e98
3. ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50 (2006) 3396-3406
4. Lee K., Chong Y., Shin H.B., Kim Y.A., Yong D., and Yum J.H. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7 (2001) 88-91
5. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases. J Antimicrob Chemother 60 (2007) 410-413
6. Lee K., Yong D., Choi Y.S., Yum J.H., Kim J.M., Woodford N., Livermore D.M., and Chong Y. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Intern J Antimicrob Agents 29 (2007) 201-206
7. Nordmann P., Cuzon G., and Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9 (2009) 228-236
8. Queenan A.M., and Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20 (2007) 440-458
9. Sawers R.G. Transcript analysis of Escherichia coli K-12 insertion element IS5. FEMS Microbiol Lett 244 (2005) 397-401
10. Song W., Bae I.K., Lee Y.N., Lee C.H., Lee S.H., and Jeong S.H. Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 45 (2007) 1180-1184
11. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., Alberti S., Bush K., and Tenover F.C. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45 (2001) 1151-1161